|
FDA allows marketing of first direct-to-consumer tests that provide genetic risk information for certain conditions
|
06 April 2017 |
|
FDA approves new eczema drug Dupixent
|
28 March 2017 |
|
FDA approves first treatment for rare form of skin cancer
|
24 March 2017 |
|
FDA approves drug to treat Parkinson's disease
|
22 March 2017 |
|
Mutual Recognition promises new framework for pharmaceutical inspections for United States and European Union
|
03 March 2017 |
|
FDA approves Odactra for house dust mite allergies
|
01 March 2017 |
|
FDA approves drug to treat Duchenne muscular dystrophy
|
10 February 2017 |
|
FDA approves first drug for spinal muscular atrophy
|
27 December 2016 |
|
FDA grants accelerated approval to new treatment for advanced ovarian cancer
|
20 December 2016 |
|
FDA research to help speed development of Zika virus vaccines and therapeutics
|
17 November 2016 |
|
FDA awards 21 grants to stimulate product development for rare diseases
|
17 October 2016 |
|
FDA launches #NaloxoneApp competition to spur innovative technologies to help reduce opioid overdose deaths
|
21 September 2016 |
|
FDA grants accelerated approval to first drug for Duchenne muscular dystrophy
|
19 September 2016 |
|
FDA updates warnings for fluoroquinolone antibiotics
|
26 July 2016 |
|
FDA approves new medication for dry eye disease
|
12 July 2016 |
|
FDA advances Precision Medicine Initiative by issuing draft guidances on next generation sequencing-based tests
|
08 July 2016 |
|
FDA targets unlawful internet sales of illegal prescription medicines during International Operation Pangea IX
|
10 June 2016 |
|
FDA approves first buprenorphine implant for treatment of opioid dependence
|
26 May 2016 |
|
FDA approves new treatment for inhalation anthrax
|
22 March 2016 |
|
FDA takes additional action to better understand safety of Essure, inform patients of potential risks
|
01 March 2016 |